Literature DB >> 18369314

A crucial role of WW45 in developing epithelial tissues in the mouse.

Joo-Hyeon Lee1, Tae-Shin Kim, Tae-Hong Yang, Bon-Kyoung Koo, Sang-Phil Oh, Kwang-Pyo Lee, Hyun-Jung Oh, Sang-Hee Lee, Young-Yun Kong, Jin-Man Kim, Dae-Sik Lim.   

Abstract

The role and molecular mechanisms of a new Hippo signalling pathway are not fully understood in mammals. Here, we generated mice that lack WW45 and revealed a crucial role for WW45 in cell-cycle exit and epithelial terminal differentiation. Many organs in the mutant mouse embryos displayed hyperplasia accompanied by defects in terminal differentiation of epithelial progenitor cells owing to impaired proliferation arrest rather than intrinsic acceleration of proliferation during differentiation. Importantly, the MST1 signalling pathway is specifically activated in differentiating epithelial cells. Moreover, WW45 is required for MST1 activation and translocation to the nucleus for subsequent LATS1/2 activation upon differentiation signal. LATS1/2 phosphorylates YAP, which, in turn, translocates from the nucleus into the cytoplasm, resulting in cell-cycle exit and terminal differentiation of epithelial progenitor cells. Collectively, these data provide compelling evidence that WW45 is a key mediator of MST1 signalling in the coordinate coupling of proliferation arrest with terminal differentiation for proper epithelial tissue development in mammals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369314      PMCID: PMC2367404          DOI: 10.1038/emboj.2008.63

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

1.  The bantam microRNA is a target of the hippo tumor-suppressor pathway.

Authors:  Riitta Nolo; Clayton M Morrison; Chunyao Tao; Xinwei Zhang; Georg Halder
Journal:  Curr Biol       Date:  2006-08-31       Impact factor: 10.834

2.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

3.  Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon.

Authors:  Michael Overholtzer; Jianmin Zhang; Gromoslaw A Smolen; Beth Muir; Wenmei Li; Dennis C Sgroi; Chu-Xia Deng; Joan S Brugge; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

4.  The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway.

Authors:  Elizabeth Silva; Yonit Tsatskis; Laura Gardano; Nic Tapon; Helen McNeill
Journal:  Curr Biol       Date:  2006-09-21       Impact factor: 10.834

5.  The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size.

Authors:  Maria Willecke; Fisun Hamaratoglu; Madhuri Kango-Singh; Ryan Udan; Chiao-Lin Chen; Chunyao Tao; Xinwei Zhang; Georg Halder
Journal:  Curr Biol       Date:  2006-09-21       Impact factor: 10.834

6.  The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila.

Authors:  Barry J Thompson; Stephen M Cohen
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

7.  Defects in yolk sac vasculogenesis, chorioallantoic fusion, and embryonic axis elongation in mice with targeted disruption of Yap65.

Authors:  Elizabeth M Morin-Kensicki; Brian N Boone; Michael Howell; Jaclyn R Stonebraker; Jeremy Teed; James G Alb; Terry R Magnuson; Wanda O'Neal; Sharon L Milgram
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

8.  The human tumour suppressor LATS1 is activated by human MOB1 at the membrane.

Authors:  Alexander Hergovich; Debora Schmitz; Brian A Hemmings
Journal:  Biochem Biophys Res Commun       Date:  2006-04-25       Impact factor: 3.575

9.  Delineation of a Fat tumor suppressor pathway.

Authors:  Eunjoo Cho; Yongqiang Feng; Cordelia Rauskolb; Sushmita Maitra; Rick Fehon; Kenneth D Irvine
Journal:  Nat Genet       Date:  2006-09-17       Impact factor: 38.330

10.  Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach.

Authors:  Lars Zender; Mona S Spector; Wen Xue; Peer Flemming; Carlos Cordon-Cardo; John Silke; Sheung-Tat Fan; John M Luk; Michael Wigler; Gregory J Hannon; David Mu; Robert Lucito; Scott Powers; Scott W Lowe
Journal:  Cell       Date:  2006-06-30       Impact factor: 41.582

View more
  95 in total

1.  MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.

Authors:  Bekir Cinar; Filiz Kisaayak Collak; Delia Lopez; Seckin Akgul; Nishit K Mukhopadhyay; Murat Kilicarslan; Daniel G Gioeli; Michael R Freeman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

2.  Crystallization and preliminary X-ray crystallographic study of the human MST2 SARAH domain.

Authors:  Jinsue Song; Hyerim Hong; Saehae Choi; Yong Hee Lee; Eiki Yamashita; Suk Chul Bae; Il Yeong Park; Soo Jae Lee
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2011-10-27

Review 3.  The Hippo pathway regulates stem cell proliferation, self-renewal, and differentiation.

Authors:  Huan Liu; Dandan Jiang; Fangtao Chi; Bin Zhao
Journal:  Protein Cell       Date:  2012-05-02       Impact factor: 14.870

Review 4.  Hippo signaling: growth control and beyond.

Authors:  Georg Halder; Randy L Johnson
Journal:  Development       Date:  2011-01       Impact factor: 6.868

5.  YAP regulates neural progenitor cell number via the TEA domain transcription factor.

Authors:  Xinwei Cao; Samuel L Pfaff; Fred H Gage
Journal:  Genes Dev       Date:  2008-11-17       Impact factor: 11.361

6.  Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Lu Zhou; Chenyi Yang; Hediye Erdjument-Bromage; David Zagzag; Matija Snuderl; Marc Ladanyi; C Oliver Hanemann; Pengbo Zhou; Matthias A Karajannis; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2014-07-14       Impact factor: 31.743

7.  Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor.

Authors:  Ana Sebio; Heinz-Josef Lenz
Journal:  Clin Cancer Res       Date:  2015-09-17       Impact factor: 12.531

8.  YAP1 is involved in replenishment of granule cell precursors following injury to the neonatal cerebellum.

Authors:  Zhaohui Yang; Alexandra L Joyner
Journal:  Dev Biol       Date:  2019-07-31       Impact factor: 3.582

Review 9.  The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Authors:  Bin Zhao; Qun-Ying Lei; Kun-Liang Guan
Journal:  Curr Opin Cell Biol       Date:  2008-11-18       Impact factor: 8.382

10.  Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.

Authors:  Li Lu; Ying Li; Soo Mi Kim; Wouter Bossuyt; Pu Liu; Qiong Qiu; Yingdi Wang; Georg Halder; Milton J Finegold; Ju-Seog Lee; Randy L Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.